These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
Delaware
|
36-3922969
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
6410 W. Howard Street, Niles, Illinois
|
60714
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Item
|
|
Page
|
|
|
|
|
|
Part I
|
|
|
|
|
|
|
|
1.
|
|
|
|
|
Consolidated Statements of Operations for the Three and Nine Months Ended October 31, 2016 and 2015
|
|
|
|
Consolidated Statements of Comprehensive (Loss) Income for the Three and Nine Months Ended October 31, 2016 and 2015
|
2
|
|
|
Consolidated Balance Sheets as of
October 31, 2016 and January 31, 2016
|
|
|
|
Consolidated Statements of Stockholders' Equity as of October 31, 2016 and January 31, 2016
|
|
|
|
Consolidated Statements of Cash Flows for the Nine Months Ended October 31, 2016 and 2015
|
|
|
|
||
|
|
|
|
|
2.
|
14
|
|
|
|
|
|
|
4.
|
19
|
|
|
|
|
|
|
Part II
|
|
|
|
6.
|
20
|
|
|
|
|
|
|
21
|
||
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||
|
Net sales
|
|
$25,302
|
|
|
$46,950
|
|
|
|
$71,230
|
|
|
$92,374
|
|
|
Cost of sales
|
21,605
|
|
32,635
|
|
|
62,561
|
|
72,578
|
|
||||
|
Gross profit
|
3,697
|
|
14,315
|
|
|
8,669
|
|
19,796
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating expenses
|
|
|
|
|
|
||||||||
|
General and administrative expenses
|
3,352
|
|
5,491
|
|
|
11,815
|
14,424
|
|
|||||
|
Selling expenses
|
1,382
|
|
1,303
|
|
|
4,236
|
3,951
|
|
|||||
|
Total operating expenses
|
4,734
|
|
6,794
|
|
|
16,051
|
|
18,375
|
|
||||
|
|
|
|
|
|
|
||||||||
|
(Loss) income from operations
|
(1,037
|
)
|
7,521
|
|
|
(7,382
|
)
|
1,421
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income from joint venture
|
—
|
|
408
|
|
|
—
|
|
524
|
|
||||
|
Loss on consolidation of joint venture
|
—
|
|
—
|
|
|
(1,620
|
)
|
—
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Interest expense, net
|
112
|
|
127
|
|
|
435
|
|
210
|
|
||||
|
(Loss) income from continuing operations before income taxes
|
(1,149
|
)
|
7,802
|
|
|
(9,437
|
)
|
1,735
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income tax expense
|
2,411
|
|
1,344
|
|
|
1,077
|
|
897
|
|
||||
|
|
|
|
|
|
|
||||||||
|
(Loss) income from continuing operations
|
(3,560
|
)
|
6,458
|
|
|
(10,514
|
)
|
838
|
|
||||
|
|
|
|
|
|
|
||||||||
|
(Loss) income from discontinued operations, net of tax
|
(203
|
)
|
(344
|
)
|
|
906
|
|
(1,770
|
)
|
||||
|
|
|
|
|
|
|
||||||||
|
Net (loss) income
|
|
($3,763
|
)
|
|
$6,114
|
|
|
|
($9,608
|
)
|
($932)
|
||
|
|
|
|
|
|
|
||||||||
|
Weighted average common shares outstanding
|
|
|
|
|
|
||||||||
|
Basic
|
7,541
|
|
7,290
|
|
|
7,457
|
|
7,273
|
|
||||
|
Diluted
|
7,541
|
|
7,367
|
|
|
7,457
|
|
7,273
|
|
||||
|
|
|
|
|
|
|
||||||||
|
(Loss) earnings per share from continuing operations
|
|
|
|
|
|
||||||||
|
Basic
|
|
($0.47
|
)
|
|
$0.89
|
|
|
($1.41)
|
$0.12
|
||||
|
Diluted
|
|
($0.47
|
)
|
|
$0.88
|
|
|
($1.41)
|
$0.12
|
||||
|
(Loss) earnings per share from discontinued operations
|
|
|
|
|
|
|
|||||||
|
Basic and diluted
|
|
($0.03
|
)
|
|
($0.05
|
)
|
|
|
$0.12
|
|
|
($0.24
|
)
|
|
(Loss) earnings per share
|
|
|
|
|
|
||||||||
|
Basic
|
($0.50)
|
|
$0.84
|
|
|
($1.29)
|
|
($0.13
|
)
|
||||
|
Diluted
|
($0.50)
|
|
$0.83
|
|
|
($1.29)
|
|
($0.13
|
)
|
||||
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||
|
Net (loss) income
|
|
($3,763
|
)
|
|
$6,114
|
|
|
|
($9,608
|
)
|
|
($932
|
)
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income
|
|
|
|
|
|
||||||||
|
Foreign currency translation adjustments, net of tax
|
(577
|
)
|
(148
|
)
|
|
457
|
|
10
|
|
||||
|
Interest rate swap, net of tax
|
—
|
|
(1
|
)
|
|
—
|
|
14
|
|
||||
|
Unrealized gain on marketable security, net of tax
|
9
|
|
—
|
|
|
5
|
|
—
|
|
||||
|
Minimum pension liability adjustment, net of tax
|
—
|
|
196
|
|
|
—
|
|
196
|
|
||||
|
Other comprehensive (loss) income
|
(568
|
)
|
47
|
|
|
462
|
|
220
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Comprehensive (loss) income
|
|
($4,331
|
)
|
|
$6,161
|
|
|
|
($9,146
|
)
|
|
($712
|
)
|
|
(In thousands except per share data)
|
October 31, 2016
|
|
January 31, 2016
|
|
||
|
ASSETS
|
Unaudited
|
|
|
|||
|
Current assets
|
|
|
||||
|
Cash and cash equivalents
|
|
$9,008
|
|
|
$16,631
|
|
|
Restricted cash
|
946
|
|
2,324
|
|
||
|
Trade accounts receivable, less allowance for doubtful accounts of $134 at October 31, 2016 and $33 at January 31, 2016
|
30,347
|
|
36,090
|
|
||
|
Inventories, net
|
14,305
|
|
15,625
|
|
||
|
Assets of discontinued operations
|
46
|
|
14,241
|
|
||
|
Assets held for sale
|
—
|
|
3,062
|
|
||
|
Cash surrender value on life insurance policies, net
|
1,291
|
|
3,049
|
|
||
|
Prepaid expenses and other current assets
|
3,201
|
|
2,397
|
|
||
|
Costs and estimated earnings in excess of billings on uncompleted contracts
|
2,260
|
|
2,463
|
|
||
|
Total current assets
|
61,404
|
|
95,882
|
|
||
|
Property, plant and equipment, net of accumulated depreciation
|
36,465
|
|
25,400
|
|
||
|
Other assets
|
|
|
||||
|
Goodwill
|
2,476
|
|
—
|
|
||
|
Note receivable from joint venture
|
—
|
|
1,905
|
|
||
|
Investment in joint venture
|
—
|
|
9,112
|
|
||
|
Other assets
|
4,912
|
|
5,824
|
|
||
|
Total other assets
|
7,388
|
|
16,841
|
|
||
|
Total assets
|
|
$105,257
|
|
|
$138,123
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
||||
|
Current liabilities
|
|
|
||||
|
Trade accounts payable
|
|
$7,548
|
|
|
$11,026
|
|
|
Accrued compensation and payroll taxes
|
3,386
|
|
4,274
|
|
||
|
Deferred compensation liability
|
1,360
|
|
6,167
|
|
||
|
Commissions and management incentives payable
|
1,520
|
|
2,874
|
|
||
|
Revolving line domestic
|
4,116
|
|
5,237
|
|
||
|
Current maturities of long-term debt
|
2,790
|
|
8,769
|
|
||
|
Customers' deposits
|
3,074
|
|
3,690
|
|
||
|
Outside commissions payable
|
1,946
|
|
1,295
|
|
||
|
Liabilities of discontinued operations
|
644
|
|
12,836
|
|
||
|
Liabilities held for sale
|
—
|
|
3,439
|
|
||
|
Billings in excess of costs and estimated earnings on uncompleted contracts
|
239
|
|
1,176
|
|
||
|
Other accrued liabilities
|
2,851
|
|
965
|
|
||
|
Income taxes payable
|
2,880
|
|
2,339
|
|
||
|
Total current liabilities
|
32,354
|
|
64,087
|
|
||
|
Long-term liabilities
|
|
|
||||
|
Long-term debt, less current maturities
|
7,164
|
|
1,493
|
|
||
|
Deferred compensation liabilities
|
3,113
|
|
3,124
|
|
||
|
Deferred tax liabilities - long-term
|
1,674
|
|
160
|
|
||
|
Other long-term liabilities
|
523
|
|
231
|
|
||
|
Total long-term liabilities
|
12,474
|
|
5,008
|
|
||
|
Stockholders' equity
|
|
|
||||
|
Common stock, $.01 par value, authorized 50,000 shares; 7,543 issued and outstanding at October 31, 2016 and 7,306 issued and outstanding at January 31, 2016
|
76
|
|
74
|
|
||
|
Additional paid-in capital
|
53,576
|
|
53,031
|
|
||
|
Treasury Stock, 45 shares at October 31, 2016 and at January 31, 2016
|
(290
|
)
|
(290
|
)
|
||
|
Retained earnings
|
10,585
|
|
20,193
|
|
||
|
Accumulated other comprehensive loss
|
(3,518
|
)
|
(3,980
|
)
|
||
|
Total stockholders' equity
|
60,429
|
|
69,028
|
|
||
|
Total liabilities and stockholders' equity
|
|
$105,257
|
|
|
$138,123
|
|
|
($ in thousands, except share data)
|
|
Additional Paid-in Capital
|
Retained Earnings
|
Treasury Stock
|
Accumulated Other Comprehensive Income (Loss)
|
Total Stockholders' Equity
|
||||||||
|
Common Stock
|
||||||||||||||
|
Total stockholders' equity at January 31, 2016
|
$74
|
$53,031
|
$20,193
|
|
($290
|
)
|
($3,980)
|
$69,028
|
||||||
|
|
|
|
|
|
|
|
||||||||
|
Net loss
|
|
|
|
($9,608
|
)
|
|
|
(9,608
|
)
|
|||||
|
Stock options exercised
|
—
|
|
117
|
|
|
|
|
117
|
|
|||||
|
Restricted shares vested, deferred shares converted and payroll taxes paid with shares
|
2
|
|
244
|
|
|
|
|
246
|
|
|||||
|
Stock-based compensation expense
|
|
184
|
|
|
|
|
184
|
|
||||||
|
Marketable security unrealized gain/loss
|
|
|
|
|
2
|
|
2
|
|
||||||
|
Foreign currency translation adjustments
|
|
|
|
|
448
|
|
448
|
|
||||||
|
Tax benefit/expense on above items
|
|
|
|
|
12
|
|
12
|
|
||||||
|
Total stockholders' equity at October
31
, 2016
|
$76
|
$53,576
|
$10,585
|
($290)
|
($3,518)
|
$60,429
|
||||||||
|
Shares
|
2016
|
|
2015
|
|
|
|
Balances at beginning of year
|
7,305,925
|
|
7,290,576
|
|
|
|
Treasury stock purchased
|
—
|
|
(44,566
|
)
|
|
|
Shares issued
|
236,635
|
|
59,915
|
|
|
|
Balances at period end
|
7,542,560
|
|
7,305,925
|
|
|
|
(In thousands)
|
Nine Months Ended October 31,
|
|||||
|
|
2016
|
|
2015
|
|
||
|
Operating activities
|
|
|
||||
|
Net loss
|
|
($9,608
|
)
|
|
($932
|
)
|
|
Adjustments to reconcile net loss to net cash flows used in operating activities
|
|
|
||||
|
Depreciation and amortization
|
4,258
|
|
4,425
|
|
||
|
Loss on consolidation of joint venture
|
1,620
|
|
—
|
|
||
|
Gain on disposal of subsidiaries
|
(186
|
)
|
—
|
|
||
|
Deferred tax (benefit) expense
|
(93
|
)
|
479
|
|
||
|
Stock-based compensation expense
|
184
|
|
137
|
|
||
|
Income from joint venture
|
—
|
|
(524
|
)
|
||
|
Cash surrender value on life insurance policies
|
(136
|
)
|
(2
|
)
|
||
|
(Gain) loss on disposal of fixed assets
|
(292
|
)
|
1
|
|
||
|
Provision on uncollectible accounts
|
500
|
|
476
|
|
||
|
Changes in operating assets and liabilities
|
|
|
||||
|
Accounts receivable
|
14,860
|
|
(17,820
|
)
|
||
|
Inventories
|
4,709
|
|
(5,687
|
)
|
||
|
Costs and estimated earnings in excess of billings on uncompleted contracts
|
(736
|
)
|
(589
|
)
|
||
|
Accounts payable
|
(5,268
|
)
|
11,206
|
|
||
|
Accrued compensation and payroll taxes
|
(9,047
|
)
|
5,686
|
|
||
|
Customers' deposits
|
(1,880
|
)
|
(1,326
|
)
|
||
|
Income taxes receivable and payable
|
671
|
|
(98
|
)
|
||
|
Prepaid expenses and other current assets
|
(742
|
)
|
1,356
|
|
||
|
Other assets and liabilities
|
(3,614
|
)
|
(6,575
|
)
|
||
|
Net cash used in operating activities
|
(4,800
|
)
|
(9,787
|
)
|
||
|
Investing activities
|
|
|
||||
|
Acquisition of interest in subsidiary, net of cash acquired
|
(4,672
|
)
|
—
|
|
||
|
Capital expenditures
|
(1,544
|
)
|
(5,971
|
)
|
||
|
Proceeds from surrender of corporate-owned life insurance policies
|
1,894
|
|
—
|
|
||
|
Receipts on loan from joint venture
|
—
|
|
1,890
|
|
||
|
Proceeds from sales of property and equipment
|
13,962
|
|
—
|
|
||
|
Net cash provided by (used in) investing activities
|
9,640
|
|
(4,081
|
)
|
||
|
Financing activities
|
|
|
||||
|
Proceeds from revolving lines
|
32,908
|
|
79,175
|
|
||
|
Proceeds from debt
|
6,048
|
|
783
|
|
||
|
Proceeds from borrowing against life insurance policies
|
—
|
|
1,916
|
|
||
|
Payments of debt on revolving lines of credit
|
(39,807
|
)
|
(63,177
|
)
|
||
|
Payments of other debt
|
(10,077
|
)
|
(1,699
|
)
|
||
|
Payments of borrowing against life insurance policies
|
—
|
|
(1,916
|
)
|
||
|
Decrease in drafts payable
|
(184
|
)
|
(122
|
)
|
||
|
Payments on capitalized lease obligations
|
(1,429
|
)
|
(659
|
)
|
||
|
Payments for repurchase of common stock
|
—
|
|
(290
|
)
|
||
|
Stock options exercised and restricted shares issued
|
363
|
|
(15
|
)
|
||
|
Net cash (used in) provided by financing activities
|
(12,178
|
)
|
13,996
|
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
(285
|
)
|
246
|
|
||
|
Net (decrease) increase in cash and cash equivalents
|
(7,623
|
)
|
374
|
|
||
|
Cash and cash equivalents - beginning of period
|
16,631
|
|
10,508
|
|
||
|
Cash and cash equivalents - end of period
|
|
$9,008
|
|
|
$10,882
|
|
|
Supplemental cash flow information
|
|
|
||||
|
Interest paid
|
|
$605
|
|
|
$836
|
|
|
Income taxes paid
|
1,281
|
|
849
|
|
||
|
Fixed assets acquired under capital leases
|
—
|
|
1,215
|
|
||
|
Funds held in escrow related to the sale of Filtration assets
|
502
|
|
—
|
|
||
|
1.
|
Basis of presentation.
The interim consolidated financial statements of MFRI, Inc. and subsidiaries ("MFRI," "Company," or "Registrant") are unaudited, but include all adjustments which the Company's management considers necessary to present fairly the financial position and results of operations for the periods presented. These adjustments consist of normal recurring adjustments. Information and footnote disclosures have been omitted pursuant to Securities and Exchange Commission ("SEC") rules and regulations. The consolidated balance sheet as of
January 31, 2016
is derived from the audited consolidated balance sheet as of that date. The results of operations for any interim period are not necessarily indicative of future or annual results. Interim financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's latest Annual Report on Form 10-K. The Company's fiscal year ends on January 31. Years and balances described as
2016
and
2015
are for the
nine months ended October 31,
2016
and
2015
, respectively.
|
|
2.
|
Business segment reporting.
As of January 31, 2016, MFRI is engaged in the manufacture and sale of products in
one
segment: Piping Systems. As described below, prior to January 29, 2016, the Company was also engaged in the manufacture and sale of products in the Filtration Products segment.
Piping Systems engineers, designs, manufactures and sells specialty piping, leak detection and location systems
. This segment's specialty piping systems include (i) industrial and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, (ii) insulated and jacketed district heating and cooling piping systems for efficient energy distribution to multiple locations from central energy plants, and (iii) oil and gas gathering flow and long lines for oil and mineral transportation. Piping Systems' leak detection and location systems are sold with many of its piping systems and on a stand-alone basis, to monitor areas where fluid intrusion may contaminate the environment, endanger personal safety, cause a fire hazard, impair essential services or damage equipment or property.
|
|
|
Three Months Ended October 31,
|
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
|
2016
|
|
2015
|
|
||||
|
Net sales
|
|
|
|
|
|
||||||||
|
Piping Systems
|
|
$25,302
|
|
|
$46,950
|
|
|
|
$71,230
|
|
|
$92,374
|
|
|
Gross profit
|
|
|
|
|
|
||||||||
|
Piping Systems
|
|
$3,697
|
|
|
$14,315
|
|
|
|
$8,669
|
|
|
$19,796
|
|
|
(Loss) income from operations
|
|
|
|
|
|
||||||||
|
Piping Systems
|
|
$640
|
|
|
$9,721
|
|
|
|
($1,775
|
)
|
|
$7,470
|
|
|
Corporate
|
|
($1,677
|
)
|
|
($2,200
|
)
|
|
(5,607
|
)
|
(6,049
|
)
|
||
|
Total (loss) income from operations
|
|
($1,037
|
)
|
|
$7,521
|
|
|
|
($7,382
|
)
|
|
$1,421
|
|
|
3.
|
Acquisition.
MFRI entered into a purchase agreement with its joint venture partner Aegion Corporation to acquire the remaining 51% ownership of
Bayou Perma-Pipe Canada, Ltd
. ("BPPC"),
a coating and insulation company in Camrose, Alberta
, which acquisition closed on
February 4, 2016
. MFRI had owned a
49%
interest in BPPC since 2009, when the joint venture was formed with Aegion to serve the oil and gas industry in Western Canada.
|
|
Total purchase consideration:
|
|
|
||
|
Cash
|
|
|
$7,587
|
|
|
Loan payable
|
|
2,000
|
|
|
|
Purchase consideration to third party
|
|
9,587
|
|
|
|
|
|
|
||
|
Fair Value of 49% Previously Held Equity Interest
|
|
7,492
|
|
|
|
Total purchase consideration
|
|
|
$17,079
|
|
|
|
|
|
||
|
Fair value of net assets acquired:
|
|
|
||
|
Cash and cash equivalents
|
|
|
$2,915
|
|
|
Property and equipment
|
|
13,124
|
|
|
|
Goodwill
|
|
2,476
|
|
|
|
Net working capital
|
|
406
|
|
|
|
Other assets (liabilities) net
|
|
(1,842
|
)
|
|
|
Net assets acquired
|
|
|
$17,079
|
|
|
4.
|
Discontinued operations.
On
January 29, 2016
, the Company sold certain assets and liabilities of its TDC Filter business based in Bolingbrook, Illinois to the Industrial Air division of CLARCOR. On January 29, 2016, the Company also sold its Nordic Air Filtration, Denmark and Nordic Air Filtration, United Arab Emirates ("U.A.E.") businesses to Hengst Holding GmbH. The aggregated sales price of these filtration businesses was
$22.0 million
, including cash proceeds of
$18.4 million
, of which
$0.5 million
is held in escrow, which terminates July 2017.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||
|
Net sales
|
|
$—
|
|
|
$19,366
|
|
|
$10,467
|
|
|
$51,677
|
|
|
|
|
|
|
|
||||||||
|
(Loss) gain on disposal of discontinued operations
|
|
($2,204
|
)
|
|
$—
|
|
|
$268
|
|
|
$—
|
|
|
Income (loss) from discontinued operations
|
|
$1,876
|
|
|
($245
|
)
|
1,216
|
|
(1,583
|
)
|
||
|
(Loss) income from discontinued operations before income taxes
|
(328
|
)
|
(245
|
)
|
1,484
|
|
(1,583
|
)
|
||||
|
Income tax (benefit) expense
|
(125
|
)
|
99
|
|
578
|
|
187
|
|
||||
|
(Loss) income from discontinued operations, net of tax
|
|
($203
|
)
|
|
($344
|
)
|
|
$906
|
|
|
($1,770
|
)
|
|
|
October 31, 2016
|
|
January 31, 2016
|
|
||
|
Current assets
|
|
|
||||
|
Cash and cash equivalents
|
|
$—
|
|
|
$5
|
|
|
Trade accounts receivable, net
|
42
|
|
5,720
|
|
||
|
Inventories, net
|
—
|
|
2,000
|
|
||
|
Other assets
|
4
|
|
60
|
|
||
|
Property, plant and equipment, net of accumulated depreciation
|
—
|
|
6,456
|
|
||
|
Total assets from discontinued operations
|
|
$46
|
|
|
$14,241
|
|
|
Current liabilities
|
|
|
||||
|
Trade accounts payable, accrued expenses and other
|
|
$644
|
|
|
$7,514
|
|
|
Current maturities of long-term debt
|
—
|
|
5,322
|
|
||
|
Total liabilities from discontinued operations
|
|
$644
|
|
|
$12,836
|
|
|
|
Nine Months Ended October 31,
|
|||||
|
|
2016
|
|
2015
|
|
||
|
Net cash used in discontinued operating activities
|
|
($673
|
)
|
|
($689
|
)
|
|
Net cash provided by (used in) discontinued investing activities
|
9,606
|
|
(1,373
|
)
|
||
|
Net cash (used in) provided by discontinued financing activities
|
(8,933
|
)
|
1,553
|
|
||
|
5.
|
Income taxes.
The determination of the consolidated provision for income taxes, deferred tax assets and liabilities and related valuation allowances requires management to make judgments and estimates. As a company with subsidiaries in foreign jurisdictions, the process of calculating income taxes involves estimating current tax obligations and exposures in each jurisdiction as well as making judgments regarding the future recoverability of deferred tax assets. Income earned in the U.A.E. is not subject to local country income tax. Additionally, the relative proportion of taxable income earned domestically versus internationally can fluctuate significantly from period to period. Changes in the estimated level of annual pre-tax income, tax laws and the results of tax audits can affect the overall effective income tax rate, which impacts the level of income tax expense and net income. Judgments and estimates related to the Company's projections and assumptions are inherently uncertain; therefore, actual results could differ materially from projections.
|
|
6.
|
Long-lived assets.
The Company evaluates long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. A factor considered important that could trigger an impairment review includes a year-to-date loss from operations. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. Piping Systems has a year-to-date loss. Based on the Company's review
there was no impairment of long-lived assets as of October 31, 2016 and January 31, 2016
.
|
|
7.
|
Other intangible assets with definite lives.
The Company owns several patents, including those covering features of its piping and electronic leak detection systems.
Patents are capitalized and amortized on a straight-line basis over a period not to exceed the legal lives of the patents.
The Company expenses costs incurred to renew or extend the term of intangible assets
. Gross patents were
$2.61 million
and
$2.59 million
as of
October 31, 2016
and
January 31, 2016
, respectively. Accumulated amortization was approximately
$2.37 million
and
$2.33 million
as of
October 31, 2016
and
January 31, 2016
, respectively. Future amortizations over the next five years ending January 31 will be
$11,500
in
2017
,
$43,150
in
2018
,
$34,150
in
2019
,
$31,150
in
2020
,
$24,800
in
2021
, and
$98,125
thereafter. Patents are included in other assets in the balance sheet.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||
|
Patent amortization expense
|
|
$12
|
|
|
$14
|
|
|
$34
|
|
|
$40
|
|
|
8.
|
Stock-based
compensation.
The Company has stock-based compensation awards that can be granted to eligible employees, officers or directors.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||
|
Stock-based compensation (benefit) expense
|
|
($83
|
)
|
|
$87
|
|
|
($367
|
)
|
|
$50
|
|
|
Restricted stock based compensation expense
|
|
$151
|
|
|
$79
|
|
|
$819
|
|
|
$337
|
|
|
|
Nine Months Ended October 31,
|
|
|
Fair value assumptions
|
2016
|
2015
|
|
Expected volatility
|
40.88% - 54.56%
|
40.88% - 59.39%
|
|
Risk free interest rate
|
.75% - 1.77%
|
.74% - 1.77%
|
|
Dividend yield
|
none
|
none
|
|
Expected life
|
5.0 - 5.1 years
|
4.9 - 5.1 years
|
|
Option activity
|
Options
|
Weighted Average Exercise Price
|
Weighted Average Remaining Contractual Term
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 31, 2016
|
720
|
|
|
$11.38
|
|
5.1
|
|
$34
|
|
|
Granted
|
22
|
|
7.33
|
|
|
|
|||
|
Exercised
|
(37
|
)
|
6.53
|
|
|
37
|
|
||
|
Expired or forfeited
|
(131
|
)
|
10.98
|
|
|
|
|||
|
Outstanding end of period
|
574
|
|
11.62
|
|
4.7
|
352
|
|
||
|
|
|
|
|
|
|||||
|
Exercisable end of period
|
485
|
|
|
$12.05
|
|
4.0
|
|
$299
|
|
|
Unvested option activity
|
Options
|
Weighted Average Grant Date Fair Value
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 31, 2016
|
166
|
|
|
$9.51
|
|
|
$—
|
|
|
Granted
|
22
|
|
7.33
|
|
|
|||
|
Vested
|
(62
|
)
|
|
|
||||
|
Expired or forfeited
|
(37
|
)
|
9.00
|
|
|
|||
|
Outstanding end of period
|
89
|
|
|
$9.31
|
|
|
$53
|
|
|
Restricted stock activity
|
Restricted Shares
|
Weighted Average Grant Price Per Share
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 31, 2016
|
163
|
|
|
$8.60
|
|
|
$1,040
|
|
|
Granted
|
241
|
|
7.26
|
|
|
|||
|
Issued
|
(94
|
)
|
|
|
||||
|
Forfeited
|
(2
|
)
|
6.92
|
|
|
|||
|
Outstanding end of period
|
308
|
|
|
$7.91
|
|
|
$2,466
|
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
|
Basic weighted average common shares outstanding
|
7,541
|
|
7,290
|
|
7,457
|
|
7,273
|
|
|
Dilutive effect of equity compensation plans
|
—
|
|
77
|
|
—
|
|
—
|
|
|
Weighted average common shares outstanding assuming full dilution
|
7,541
|
|
7,367
|
|
7,457
|
|
7,273
|
|
|
|
|
|
|
|
||||
|
Stock options not included in the computation of diluted earnings per share of common stock because the option exercise prices exceeded the average market prices of the common shares
|
270
|
|
753
|
|
336
|
|
743
|
|
|
|
|
|
|
|
||||
|
Stock options with an exercise price below the average market price
|
304
|
|
—
|
|
238
|
|
10
|
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
||||
|
Interest expense
|
|
$164
|
|
|
$247
|
|
|
$556
|
|
|
$615
|
|
|
Interest income
|
(52
|
)
|
(120
|
)
|
(121
|
)
|
(405
|
)
|
||||
|
Interest expense, net
|
|
$112
|
|
|
$127
|
|
|
$435
|
|
|
$210
|
|
|
13.
|
Other accrued liabilities.
In the second quarter, the Company recorded a legal settlement accrual of
$0.8 million
, which is included in other accrued liabilities.
|
|
14.
|
Recent accounting pronouncements
.
In October 2016, the Financial Accounting Standards Board ("FASB") issued authoritative guidance requiring the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs rather than when transferred to a third party as required under the current guidance. The new guidance is effective for the Company beginning February 1, 2018, with early adoption permitted. The Company is currently assessing the potential impact the guidance will have upon adoption.
|
|
|
Three Months Ended October 31,
|
Nine Months Ended October 31,
|
||||||||||||||||||
|
($ in thousands)
|
2016
|
|
%
|
2015
|
|
%
|
% Increase (decrease)
|
2016
|
|
%
|
|
2015
|
|
%
|
|
% Increase (decrease)
|
||||
|
Net sales
|
$25,302
|
|
$46,950
|
|
(46
|
)%
|
$71,230
|
|
$92,374
|
|
(23
|
)%
|
||||||||
|
Gross profit
|
3,697
|
|
15
|
%
|
14,315
|
|
30
|
%
|
(74
|
)%
|
8,669
|
12
|
%
|
19,796
|
21
|
%
|
(56
|
)%
|
||
|
General and administrative expenses
|
1,675
|
|
7
|
%
|
3,291
|
|
7
|
%
|
(11
|
)%
|
6,208
|
|
9
|
%
|
8,375
|
9
|
%
|
(26
|
)%
|
|
|
Selling expenses
|
1,382
|
|
5
|
%
|
1,303
|
|
3
|
%
|
6
|
%
|
4,236
|
|
6
|
%
|
3,951
|
4
|
%
|
7
|
%
|
|
|
Income (loss) from operations
|
640
|
|
3
|
%
|
9,721
|
|
21
|
%
|
(93
|
)%
|
(1,775
|
)
|
(2
|
)%
|
7,470
|
|
8
|
%
|
(124
|
)%
|
|
Loss on consolidation of joint venture
|
—
|
|
|
—
|
|
|
|
(1,620
|
)
|
|
—
|
|
|
|
||||||
|
•
|
competitive pricing pressure and weak infrastructure spending in district heating and cooling markets
|
|
•
|
reduced volume in oil and gas operations resulting from low oil prices
|
|
•
|
competitive pricing pressure and weak infrastructure spending in district heating and cooling markets
|
|
•
|
reduced volume in oil and gas operations resulting from low oil prices
|
|
•
|
a non-cash loss of $1.6 million from the consolidation of the joint venture
|
|
•
|
a one-time $0.8 million lawsuit settlement
|
|
•
|
$0.3 million in severance costs
|
|
•
|
increased professional services associated with the changes in the Company's business structure to concentrate on a single line of business.
|
|
10.1
|
Executive Employment Agreement by and between MFRI, Inc. and David Mansfield dated as of October 19, 2016
|
|
31
|
Rule 13a - 14(a)/15d - 14(a) Certifications
(1) Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
(2) Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32
|
Section 1350 Certifications (Chief Executive Officer and Chief Financial Officer certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)
|
|
101.INS
|
XBRL Instance
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation
|
|
101.DEF
|
XBRL Taxonomy Extension Definition
|
|
101.LAB
|
XBRL Taxonomy Extension Labels
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation
|
|
Date:
|
December 13, 2016
|
/s/ David J. Mansfield
|
|
|
|
David J. Mansfield
|
|
|
|
President and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
Date:
|
December 13, 2016
|
/s/ Karl J. Schmidt
|
|
|
|
Karl J. Schmidt
|
|
|
|
Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|